HOWL — Werewolf Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Werewolf Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	158	129	134	111	57
Net Total Receivables	—	6.93	1.35	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	161	140	138	113	58.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16.3	17.5	14.8	12.3	9.9
Other Long Term Assets
Total Assets	179	160	175	127	69.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11.9	24	19.4	15.2	36.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	26.5	37.9	63.5	53.5	44.6
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	153	122	111	73.4	24.8
Total Liabilities & Shareholders' Equity	179	160	175	127	69.4
Total Common Shares Outstanding